T1 Mapping Basic Techniques and Clinical Applications

JACC: Cardiovascular Imaging

Volumn 9, Issue 1, 2016, Pages 67-81

  Taylor, Andrew J ^a   Salerno, Michael ^b   Dharmakumar, Rohan ^c   Jerosch Herold, Michael ^d  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fibrosis; interstitium; magnetic resonance imaging; myocardium

Indexed keywords

CONTRAST MEDIUM;

AORTA VALVE DISEASE; CARDIAC IMAGING; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; FIBROSING ALVEOLITIS; HEART AMYLOIDOSIS; HEART INFARCTION; HEART MUSCLE; HEMOSIDEROSIS; HUMAN; HYPERTENSION; INTERSTITIUM; MYOCARDITIS; PRIORITY JOURNAL; PROCEDURES; REVIEW; CARDIAC MUSCLE; FIBROSIS; HEART DISEASES; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS;

CONTRAST MEDIA; FIBROSIS; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84952882248     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.11.005     Document Type: Review

References (84)

1. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, and M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circ Cardiovasc Imaging 3 2010 727 734
2. S. Flacke, J.S. Allen, J.M. Chia, and et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model Radiology 226 2003 731 738
3. A.S. Flett, M.P. Hayward, M.T. Ashworth, and et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
4. L. Iles, H. Pfluger, A. Phrommintikul, and et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
5. M. Jerosch-Herold, D.C. Sheridan, J.D. Kushner, and et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy Am J Physiol Heart Circ Physiol 295 2008 H1234 H1242
6. C. Klein, S.G. Nekolla, T. Balbach, and et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure J Magn Reson Imaging 20 2004 588 593
7. J.C. Moon, D.R. Messroghli, P. Kellman, and et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement J Cardiovasc Magn Reson 15 2013 92
8. P. Kellman, J.R. Wilson, H. Xue, M. Ugander, and A.E. Arai Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method J Cardiovasc Magn Reson 14 2012 63
9. M. Salerno, R. Janardhanan, R.S. Jiji, and et al. Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping J Magn Reson Imaging 38 2013 217 224
10. M.S. Nacif, E.B. Turkbey, N. Gai, and et al. Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences J Magn Reson Imaging 34 2011 1367 1373
11. S.J. Flacke, S.E. Fischer, and C.H. Lorenz Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction Radiology 218 2001 703 710
12. D.R. Messroghli, A. Radjenovic, S. Kozerke, D.M. Higgins, M.U. Sivananthan, and J.P. Ridgway Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart Magn Reson Med 52 2004 141 146
13. D.R. Messroghli, A. Greiser, M. Frohlich, R. Dietz, and J. Schulz-Menger Optimization and validation of a fully-integrated pulse sequence for modified Look-Locker inversion-recovery (MOLLI) T1 mapping of the heart J Magn Reson Imaging 26 2007 1081 1086
14. E.B. Schelbert, S.M. Testa, C.G. Meier, and et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus J Cardiovasc Magn Reson 13 2011 16
15. S.K. Piechnik, V.M. Ferreira, E. Dall'Armellina, and et al. Shortened modified Look-Locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold J Cardiovasc Magn Reson 12 2010 69
16. P. Schmitt, M.A. Griswold, P.M. Jakob, and et al. Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density Magn Reson Med 51 2004 661 667
17. M.D. Robson, S.K. Piechnik, E.M. Tunnicliffe, and S. Neubauer T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences Magn Reson Med 70 2013 664 670
18. D.M. Higgins, J.P. Ridgway, A. Radjenovic, U.M. Sivananthan, and M.A. Smith T1 measurement using a short acquisition period for quantitative cardiac applications Med Phys 32 2005 1738 1746
19. K. Chow, J.A. Flewitt, J.D. Green, J.J. Pagano, M.G. Friedrich, and R.B. Thompson Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping Magn Reson Med 71 2014 2082 2095
20. M. Fitts, E. Breton, E.G. Kholmovski, and et al. Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence Magn Reson Med 70 2013 1274 1282
21. T. Song, J.A. Stainsby, V.B. Ho, M.N. Hood, and G.S. Slavin Flexible cardiac T1 mapping using a modified Look-Locker acquisition with saturation recovery Magn Reson Med 67 2012 622 627
22. S. Roujol, S. Weingartner, M. Foppa, and et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE Radiology 272 2014 683 689
23. H. Arheden, M. Saeed, C.B. Higgins, and et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats Radiology 211 1999 698 708
24. T.G. Neilan, O.R. Coelho-Filho, R.V. Shah, and et al. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions J Am Coll Cardiol Img 6 2013 672 683
25. S. Bull, S.K. White, S.K. Piechnik, and et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis Heart 99 2013 932 937
26. A.H. Ellims, L.M. Iles, L.H. Ling, and et al. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype Eur Heart J Cardiovasc Imaging 15 2014 1108 1116
27. C.T. Sibley, R.A. Noureldin, N. Gai, and et al. T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy Radiology 265 2012 724 732
28. C.A. Miller, J. Naish, P. Bishop, and et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume Circ Cardiovasc Imaging 6 2013 373 383
29. S.K. White, D.M. Sado, M. Fontana, and et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique J Am Coll Cardiol Img 6 2013 955 962
30. P. Sparrow, D.R. Messroghli, S. Reid, J.P. Ridgway, G. Bainbridge, and M.U. Sivananthan Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study Am J Roentgenol 187 2006 W630 W635
31. A.S. Flett, D.M. Sado, G. Quarta, and et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study Eur Heart J Cardiovasc Imaging 13 2012 819 826
32. A.J. McLellan, M.P. Schlaich, A.J. Taylor, and et al. Reverse cardiac remodeling after renal denervation: atrial electrophysiologic and structural changes associated with blood pressure lowering Heart Rhythm 12 2015 982 990
33. D.R. Messroghli, S. Nordmeyer, T. Dietrich, and et al. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping Circ Cardiovasc Imaging 4 2011 636 640
34. O.R. Coelho-Filho, R.V. Shah, T.G. Neilan, and et al. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone J Am Heart Assoc 3 2014 e000790
35. S. Kuruvilla, R. Janardhanan, P. Antkowiak, and et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone J Am Coll Cardiol Img 8 2015 172 180
36. T.A. Treibel, F. Zemrak, D.M. Sado, and et al. Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17 2015 74
37. V.M. Ferreira, S.K. Piechnik, E. Dall'Armellina, and et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance J Cardiovasc Magn Reson 14 2012 42
38. D. Carrick, C. Haig, S. Rauhalammi, and et al. Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors Eur Heart J 2015 Aug 10 [E-pub ahead of print]
39. M. Ugander, A.J. Oki, L.Y. Hsu, and et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology Eur Heart J 33 2012 1268 1278
40. W. Chan, S.J. Duffy, D.A. White, and et al. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion J Am Coll Cardiol Img 5 2012 884 893
41. D. Carrick, C. Haig, S. Rauhalammi, and et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis J Am Coll Cardiol Img 8 2015 779 789
42. A. Kali, I. Cokic, R.L. Tang, and et al. Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T Circ Cardiovasc Imaging 7 2014 471 481
43. A. Kali, E.Y. Choi, B. Sharif, and et al. Native T1 mapping by 3-T CMR imaging for characterization of chronic myocardial infarctions J Am Coll Cardiol Img 8 2015 1019 1030
44. D.R. Messroghli, K. Walters, S. Plein, and et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction Magn Reson Med 58 2007 34 40
45. A. Heling, R. Zimmermann, S. Kostin, and et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium Circ Res 86 2000 846 853
46. C.A. Beltrami, N. Finato, M. Rocco, and et al. The cellular basis of dilated cardiomyopathy in humans J Mol Cell Cardiol 27 1995 291 305
47. A.H. Ellims, L.M. Iles, L.H. Ling, J.L. Hare, D.M. Kaye, and A.J. Taylor Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction J Cardiovasc Magn Reson 14 2012 76
48. C.Y. Ho, S.A. Abbasi, T.G. Neilan, and et al. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy Circ Cardiovasc Imaging 6 2013 415 422
49. J.C. Moon, E. Reed, M.N. Sheppard, and et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
50. S.M. Banypersad, M. Fontana, V. Maestrini, and et al. T1 mapping and survival in systemic light-chain amyloidosis Eur Heart J 36 2015 244 251
51. T.C. Wong, K. Piehler, C.G. Meier, and et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality Circulation 126 2012 1206 1216
52. V.O. Puntmann, T. Voigt, Z. Chen, and et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy J Am Coll Cardiol Img 6 2013 475 484
53. S.M. Banypersad, D.M. Sado, A.S. Flett, and et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study Circ Cardiovasc Imaging 6 2013 34 39
54. J. Brooks, C.M. Kramer, and M. Salerno Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping J Magn Reson Imaging 38 2013 1591 1595
55. F.P. Mongeon, M. Jerosch-Herold, O.R. Coelho-Filho, R. Blankstein, R.H. Falk, and R.Y. Kwong Quantification of extracellular matrix expansion by CMR in infiltrative heart disease J Am Coll Cardiol Img 5 2012 897 907
56. J.A. White, H.W. Kim, D. Shah, and et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis J Am Coll Cardiol Img 7 2014 143 156
57. S. Pica, D.M. Sado, V. Maestrini, and et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance J Cardiovasc Magn Reson 16 2014 99
58. V.O. Puntmann, D. D'Cruz, Z. Smith, and et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus Circ Cardiovasc Imaging 6 2013 295 301
59. A. Barison, L. Gargani, D. De Marchi, and et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance Eur Heart J Cardiovasc Imaging 16 2015 74 80
60. T.G. Neilan, O.R. Coelho-Filho, R.V. Shah, and et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy Am J Cardiol 111 2013 717 722
61. R. Hinojar, L. Foote, E. Arroyo Ucar, and et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR J Am Coll Cardiol Img 8 2015 37 46
62. V.M. Ferreira, S.K. Piechnik, E. Dall'Armellina, and et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents J Cardiovasc Magn Reson 16 2014 36
63. P.S. Biesbroek, A.M. Beek, H.W. Niessen, and A.C. van Rossum T1-mapping in a case of acute biopsy-proven myocarditis with an apparently normal CMR: 'times are a-changing' Eur Heart J 2015 Jul 18 [E-pub ahead of print]
64. A.J. Taylor, and W. Chan Post-infarction LV remodeling remote changes do not necessarily occur remotely from time of infarction J Am Coll Cardiol Img 8 2015 790 792
65. J.P. Carpenter, T. He, P. Kirk, and et al. On T2∗magnetic resonance and cardiac iron Circulation 123 2011 1519 1528
66. A. Kali, A. Kumar, I. Cokic, and et al. Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation Circ Cardiovasc Imaging 6 2013 218 228
67. A. Bjornerud, L.O. Johansson, K. Briley-Saebo, and H.K. Ahlstrom Assessment of T1 and T2∗effects in vivo and ex vivo using iron oxide nanoparticles in steady state - dependence on blood volume and water exchange Magn Reson Med 47 2002 461 471
68. J.P. Carpenter, T. He, P. Kirk, and et al. Calibration of myocardial T2 and T1 against iron concentration J Cardiovasc Magn Reson 16 2014 62
69. D.M. Sado, V. Maestrini, S.K. Piechnik, and et al. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload J Magn Reson Imaging 41 2015 1505 1511
70. Y. Feng, T. He, J.P. Carpenter, and et al. In vivo comparison of myocardial T1 with T2 and T2∗in thalassaemia major J Magn Reson Imaging 38 2013 588 593
71. N.A. Ntusi, S.K. Piechnik, J.M. Francis, and et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping J Am Coll Cardiol Img 8 2015 526 536
72. T.D. Karamitsos, S.K. Piechnik, S.M. Banypersad, and et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis J Am Coll Cardiol Img 6 2013 488 497
73. A.C. Ng, D. Auger, V. Delgado, and et al. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T(1) mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study Circ Cardiovasc Imaging 5 2012 51 59
74. C. Jellis, J. Wright, D. Kennedy, and et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy Circ Cardiovasc Imaging 4 2011 693 702
75. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
76. M.T. Maeder, and D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
77. M.Y. Su, L.Y. Lin, Y.H. Tseng, and et al. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF J Am Coll Cardiol Img 7 2014 991 997
78. J. Mascherbauer, B.A. Marzluf, C. Tufaro, and et al. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction Circ Cardiovasc Imaging 6 2013 1056 1065
79. A.H. Ellims, J.A. Shaw, D. Stub, and et al. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness J Am Coll Cardiol 63 2014 1112 1118
80. S.P. Lee, W. Lee, J.M. Lee, and et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis Radiology 274 2015 359 369
81. L.M. Iles, A.H. Ellims, H. Llewellyn, and et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis Eur Heart J Cardiovasc Imaging 16 2015 14 22
82. M. Fontana, S.K. White, S.M. Banypersad, and et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR J Cardiovasc Magn Reson 14 2012 88
83. C.D. de Ravenstein, C. Bouzin, S. Lazam, and et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from modified Look-Locker imaging (MOLLI) T1 mapping at 3 T J Cardiovasc Magn Res 17 2015 48
84. F. aus dem Siepen, S.J. Buss, D. Messroghli, and et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy Eur Heart J Cardiovasc Imaging 16 2015 210 216